Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Titel:
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Auteur:
Mittra, Arjun Coyne, Geraldine H. O’ Sullivan Zlott, Jennifer Kummar, Shivaani Meehan, Robert Rubinstein, Lawrence Juwara, Lamin Wilsker, Deborah Ji, Jiuping Miller, Brandon Navas, Tony Ferry-Galow, Katherine V. Voth, Andrea Regier Chang, Ting-Chia Jiwani, Shahanawaz Parchment, Ralph E. Doroshow, James H. Chen, Alice P.